Your browser doesn't support javascript.
loading
Phase 2 open-label, multicenter, single-arm study of cemiplimab in patients with locally advanced basal cell carcinoma after hedgehog inhibitor therapy: Extended follow-up.
Stratigos, Alexander J; Sekulic, Aleksandar; Peris, Ketty; Bechter, Oliver; Prey, Sorilla; Lewis, Karl D; Basset-Seguin, Nicole; Chang, Anne Lynn S; Dalle, Stéphane; Fernández Orland, Almudena; Licitra, Lisa; Robert, Caroline; Ulrich, Claas; Hauschild, Axel; Migden, Michael R; Dummer, Reinhard; Yoo, Suk-Young; Okoye, Emmanuel; Bassukas, Ioannis; Loquai, Carmen; De Giorgi, Vincenzo; Eroglu, Zeynep; Gutzmer, Ralf; Ulrich, Jens; Puig, Susana; Inocencio, Timothy J; Chen, Chieh-I; LaFontaine, Patrick R; Seebach, Frank; Lowy, Israel; Fury, Matthew G.
Afiliação
  • Stratigos AJ; Department of Dermatology-Venereology, Andreas Sygros Hospital-National and Kapodistrian University of Athens, Athens, Greece. Electronic address: alstrat2@gmail.com.
  • Sekulic A; Department of Dermatology, Arizona Mayo Clinic, Scottsdale, Arizona.
  • Peris K; Dipartimento di Scienze Mediche e Chirurgiche, UOC di Dermatologia, Fondazione Policlinico Universitario A. Gemelli - IRCCS, Rome, Italy.
  • Bechter O; Department of General Medical Oncology, University Hospitals, Leuven, Belgium.
  • Prey S; Department of Dermatology, Bordeaux University Hospital, Bordeaux, France.
  • Lewis KD; School of Medicine, University of Colorado, Aurora, Colorado.
  • Basset-Seguin N; Department of Dermatology, Hôpital Saint-Louis, Paris, France.
  • Chang ALS; Department of Dermatology, Stanford University School of Medicine, Stanford, California.
  • Dalle S; Department of Dermatology, Centre Hospitalier Lyon-Sud, Lyon, France.
  • Fernández Orland A; Department of Dermatology, Hospital Universitario Virgen Macarena, Seville, Spain.
  • Licitra L; Medical Oncology Head and Neck Cancer Department, Fondazione IRCCS Istituto Nazionale dei Tumori and University of Milan, Milan, Italy.
  • Robert C; Dermatology Unit, Gustave Roussy Cancer Center and Paris-Saclay University, Villejuif, France.
  • Ulrich C; Skin Cancer Centre, Charite-Universitätsmedizin Berlin, Berlin, Germany.
  • Hauschild A; Department of Dermatology, University of Kiel, Kiel, Germany.
  • Migden MR; Departments of Dermatology and Head and Neck Surgery, University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Dummer R; Department of Dermatology, University Hospital Zurich, Zurich, Switzerland.
  • Yoo SY; Regeneron Pharmaceuticals, Inc, Tarrytown, New York.
  • Okoye E; Regeneron Pharmaceuticals, Inc, Tarrytown, New York.
  • Bassukas I; Faculty of Medicine, Department of Skin and Venereal Diseases, School of Health Sciences, University of Ioannina, Ioannina, Greece.
  • Loquai C; Department of Dermatology, University Medical Center Mainz, Mainz, Germany.
  • De Giorgi V; Departments of Dermatology, Human Pathology, and Oncology, University of Florence, Florence, Italy.
  • Eroglu Z; Department of Cutaneous Oncology, Moffitt Cancer Center, Tampa, Florida.
  • Gutzmer R; Johannes Wesling Medical Center, Ruhr University Bochum, Minden, Germany.
  • Ulrich J; Academic Teaching Hospital of the University Otto von Guericke Magdeburg, Quedlinburg, Germany.
  • Puig S; Dermatology Department, Hospital Clinic of Barcelona, University of Barcelona, Barcelona, Spain.
  • Inocencio TJ; Regeneron Pharmaceuticals, Inc, Tarrytown, New York.
  • Chen CI; Regeneron Pharmaceuticals, Inc, Tarrytown, New York.
  • LaFontaine PR; Sanofi, Cambridge, Massachusetts.
  • Seebach F; Regeneron Pharmaceuticals, Inc, Tarrytown, New York.
  • Lowy I; Regeneron Pharmaceuticals, Inc, Tarrytown, New York.
  • Fury MG; Regeneron Pharmaceuticals, Inc, Tarrytown, New York.
J Am Acad Dermatol ; 90(2): 414-418, 2024 Feb.
Article em En | MEDLINE | ID: mdl-37839734

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Cutâneas / Carcinoma Basocelular / Anticorpos Monoclonais Humanizados Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Cutâneas / Carcinoma Basocelular / Anticorpos Monoclonais Humanizados Idioma: En Ano de publicação: 2024 Tipo de documento: Article